G1/S transition
G1/S transition is a crucial phase in the cell cycle that marks the transition from the G1 phase, where the cell grows, to the S phase, where DNA replication occurs. This transition is tightly regulated by various proteins and enzymes to ensure that the cell is ready to replicate its DNA and divide. The G1/S transition is a key checkpoint in the cell cycle, ensuring that cells do not replicate damaged DNA or divide under unfavorable conditions.
Regulation of G1/S Transition
The regulation of the G1/S transition involves a complex network of cyclin-dependent kinases (CDKs) and their regulatory subunits, cyclins. The most important of these is the cyclin D-CDK4/6 complex in early G1 and the cyclin E-CDK2 complex in late G1, which phosphorylate the retinoblastoma protein (Rb) and other proteins to promote progression into the S phase.
p53 protein also plays a critical role in the G1/S transition. It can induce cell cycle arrest in response to DNA damage or other stress signals, thus preventing the replication of damaged DNA. p53 acts primarily through the transcriptional activation of the CDK inhibitor p21, which inhibits CDK activity, thereby halting the cell cycle.
Molecular Mechanisms
The molecular mechanisms underlying the G1/S transition involve several key steps: 1. **Cyclin D synthesis** is induced by mitogenic signals, leading to the formation of the cyclin D-CDK4/6 complex. 2. **Rb phosphorylation**: The cyclin D-CDK4/6 complex phosphorylates Rb, partially releasing E2F transcription factors that were bound and inhibited by Rb. 3. **E2F activation**: Free E2F acts as a transcription factor for genes essential for S phase entry, including cyclin E. 4. **Cyclin E-CDK2 activation**: Cyclin E forms a complex with CDK2, which further phosphorylates Rb, completely releasing all E2F. This positive feedback loop ensures the cell's commitment to the S phase. 5. **p53-p21 pathway activation** in response to DNA damage or stress signals, leading to cell cycle arrest if necessary.
Clinical Significance
Abnormalities in the G1/S transition can lead to uncontrolled cell proliferation and cancer. For example, mutations in the Rb gene, leading to a loss of Rb function, can remove the cell cycle brake, allowing for continuous cell division. Similarly, mutations in p53, one of the most common mutations in cancer, can prevent the cell from arresting the cell cycle in response to DNA damage, leading to the accumulation of mutations and cancer progression.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD